Antiplatelet Therapy in Patients With COVID-19-More Is Less?

B. Spaetgens; M. Nagy; H. ten Cate

doi:10.1001/jama.2021.23866

Antiplatelet Therapy in Patients With COVID-19-More Is Less?

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	223-224
Number of pages	2
Journal	JAMA-Journal of the American Medical Association
Volume	327
Issue number	3
DOIs	https://doi.org/10.1001/jama.2021.23866
Publication status	Published - 18 Jan 2022

Keywords

Anticoagulants
COVID-19
Hospital Mortality
Humans
Platelet Aggregation Inhibitors/therapeutic use
SARS-CoV-2
PLATELETS

Access to Document

10.1001/jama.2021.23866

Cite this

@article{0c553687f2204e2aaf0dd294c8772d9a,

title = "Antiplatelet Therapy in Patients With COVID-19-More Is Less?",

keywords = "Anticoagulants, COVID-19, Hospital Mortality, Humans, Platelet Aggregation Inhibitors/therapeutic use, SARS-CoV-2, PLATELETS",

author = "B. Spaetgens and M. Nagy and {ten Cate}, H.",

year = "2022",

month = jan,

day = "18",

doi = "10.1001/jama.2021.23866",

language = "English",

volume = "327",

pages = "223--224",

journal = "JAMA-Journal of the American Medical Association",

issn = "0098-7484",